glp 1 atherosclerosis The Cardiovascular Biology of Glucagon-like Peptide-1: Cell Metabolism Cardiovascular Protective Properties of GLP-1

Donor alone transiently decreases food intake and body weight, but both rebounded over time

Treatment with the glucagon-like peptide-1 analogue liraglutide is associated with amelioration of disease activity in a prospective cohort study of patients with inflammatory arthritis

GLP-1 medications work by mimicking the effects of the GLP-1 hormone, which is produced within the small intestine

Risk of esophageal and gastric cancer in patients with type 2 diabetes receiving glucagon-like peptide-1 receptor agonists (GLP-1 RAs): a national analysis

Patients should work closely with a renal dietitian before starting any weight loss medication